Comparisons of baseline characteristics between LN patients with and without follow-up data. Table S2. Risk of CVD mortality by HDL-C category and each 0.1Â mmol/L increase of HDL-C levels. (DOCX 78Â kb
The biomarker hazard ratios using Cox proportional hazards models that included GN vs non-GN CKD and...
Table S2. Adjusted estimates for the effect of baseline risk factors on cancer mortality from Cox-PH...
Effect of different types of statins on lipid variables in CHD patients. (DOC 36Â kb
Kaplan-Meier survival curves for CVD mortality in three HDL-C groups of LN patients. There were no s...
Table S1. Association of HDL-C levels with microalbuminuria after adjusting for clinical variables (...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Table S1. Multivariable-adjusted hazard ratios of atherosclerotic cardiovascular composite endpoints...
Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...
All non-vascular SAEs, by particular baseline characteristics. Figure S2. All non-vascular SAEs, by ...
Hazard ratios and 95% confidence intervals for associations of low-density lipoprotein cholesterol w...
Changes in lipid profiles after 8-week drug treatment. Figure S1. CONSORT 2010 flow diagram. Figure ...
Sensitivity analysis of the association between CEC and the incidence of cardiovascular events (high...
Table S1. Adjusted estimates for the effect of baseline risk factors on cardiovascular mortality fro...
Figure S2. Survival curves for comparing the high-ferritin (HF) and low-ferritin (LF) groups after e...
Table S1. Changes of lipid parameters in HCC patients without cirrhosis, compensated cirrhosis and d...
The biomarker hazard ratios using Cox proportional hazards models that included GN vs non-GN CKD and...
Table S2. Adjusted estimates for the effect of baseline risk factors on cancer mortality from Cox-PH...
Effect of different types of statins on lipid variables in CHD patients. (DOC 36Â kb
Kaplan-Meier survival curves for CVD mortality in three HDL-C groups of LN patients. There were no s...
Table S1. Association of HDL-C levels with microalbuminuria after adjusting for clinical variables (...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Table S1. Multivariable-adjusted hazard ratios of atherosclerotic cardiovascular composite endpoints...
Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...
All non-vascular SAEs, by particular baseline characteristics. Figure S2. All non-vascular SAEs, by ...
Hazard ratios and 95% confidence intervals for associations of low-density lipoprotein cholesterol w...
Changes in lipid profiles after 8-week drug treatment. Figure S1. CONSORT 2010 flow diagram. Figure ...
Sensitivity analysis of the association between CEC and the incidence of cardiovascular events (high...
Table S1. Adjusted estimates for the effect of baseline risk factors on cardiovascular mortality fro...
Figure S2. Survival curves for comparing the high-ferritin (HF) and low-ferritin (LF) groups after e...
Table S1. Changes of lipid parameters in HCC patients without cirrhosis, compensated cirrhosis and d...
The biomarker hazard ratios using Cox proportional hazards models that included GN vs non-GN CKD and...
Table S2. Adjusted estimates for the effect of baseline risk factors on cancer mortality from Cox-PH...
Effect of different types of statins on lipid variables in CHD patients. (DOC 36Â kb
DOI
Add to ORKG